Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link Semaglutide vs Tirzepatide, Cagrilintide, and Retatrutide: Mechanisms & Research Insights Unlocking the Power of Cagrilintide: A Deep Dive Into Dosage Schedules and What to Expect Feast Tirzepatide vs. Semaglutide: Which Is Better? New Leaf Online Full article: Pharmacotherapy for Obesity: Recent Updates CagriSema vs Tirzepatide: Head to Head Obesity Trial Results Yasir Zaroug posted on the topic LinkedIn